Paper8096847
Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.
Kojima S and 2 others. J Cell Biol, 1993. Cited by 278 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. Papers, record 8096847. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8096847
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endothelium, Vascular | Major topic |
| Transforming Growth Factor beta | Major topic |
| Transglutaminases | Major topic |
| Animals | |
| Antibodies | |
| Aorta | |
| Bacitracin | |
| Biotransformation | |
| Cattle | |
| Cells, Cultured | |
| Cystamine | |
| Fibrinolysin | |
| Plasminogen Activators | |
| Vitamin A |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA23753 | NCI NIH HHS | United States | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03487861 | Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis | Results |
Source ClinicalTrials.gov
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,670,773 | Calcium-induced intracellular cross-linking of lipocortin I by tissue transglutaminase in A431 cells. Augmentation by membrane phospholipids. | J Biol Chem | 1991 | https://conductscience.org/library/papers/1670773 | PubMed |
| 2 | 3,461,562 | Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. | Science | 1986 | https://conductscience.org/library/papers/3461562 | PubMed |
| 3 | 1,704,222 | Vitronectin in the substratum of endothelial cells is cross-linked and phosphorylated. | Biochem Biophys Res Commun | 1991 | https://conductscience.org/library/papers/1704222 | PubMed |
| 4 | 2,024,887 | Mechanisms controlling the extracellular activity of basic fibroblast growth factor and transforming growth factor. | Ann N Y Acad Sci | 1991 | https://conductscience.org/library/papers/2024887 | PubMed |
| 5 | 1,828,468 | Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration. | J Cell Biol | 1991 | https://conductscience.org/library/papers/1828468 | PubMed |
| 6 | 1,908,141 | Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo. | Thromb Haemost | 1991 | https://conductscience.org/library/papers/1908141 | PubMed |
| 7 | 2,881,577 | Inhibition of protein cross-linking in Ca2+-enriched human erythrocytes and activated platelets. | Biochemistry | 1987 | https://conductscience.org/library/papers/2881577 | PubMed |
| 8 | 2,887,223 | The transglutaminase in vascular cells and tissues could provide an alternate pathway for fibrin stabilization. | Blood | 1987 | https://conductscience.org/library/papers/2887223 | PubMed |
| 9 | 3,114,269 | The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. | J Cell Biol | 1987 | https://conductscience.org/library/papers/3114269 | PubMed |
| 10 | 2,967,299 | Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. | J Cell Biol | 1988 | https://conductscience.org/library/papers/2967299 | PubMed |
| 11 | 2,900,016 | Human erythrocyte transglutaminase: purification and preliminary characterisation. | Biol Chem Hoppe Seyler | 1988 | https://conductscience.org/library/papers/2900016 | PubMed |
| 12 | 2,900,023 | Amino acid sequence of guinea pig liver transglutaminase from its cDNA sequence. | Biochemistry | 1988 | https://conductscience.org/library/papers/2900023 | PubMed |
| 13 | 2,910,889 | Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture. | J Cell Physiol | 1989 | https://conductscience.org/library/papers/2910889 | PubMed |
| 14 | 2,920,041 | Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. | Biochem Biophys Res Commun | 1989 | https://conductscience.org/library/papers/2920041 | PubMed |
| 15 | 2,565,341 | Regulation of tissue transglutaminase gene expression as a molecular model for retinoid effects on proliferation and differentiation. | J Cell Biochem | 1989 | https://conductscience.org/library/papers/2565341 | PubMed |
| 16 | 2,734,305 | An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2734305 | PubMed |
| 17 | 2,526,131 | Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. | J Cell Biol | 1989 | https://conductscience.org/library/papers/2526131 | PubMed |
| 18 | 2,569,868 | GTP hydrolysis by guinea pig liver transglutaminase. | Biochem Biophys Res Commun | 1989 | https://conductscience.org/library/papers/2569868 | PubMed |
| 19 | 2,572,221 | Bovine aortic endothelial cell transglutaminase. Enzyme characterization and regulation of activity. | Biochem J | 1989 | https://conductscience.org/library/papers/2572221 | PubMed |
| 20 | 2,572,599 | Retinol-induced morphological changes of cultured bovine endothelial cells are accompanied by a marked increase in transglutaminase. | J Biol Chem | 1989 | https://conductscience.org/library/papers/2572599 | PubMed |
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 278 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,555,608 | The role of transglutaminase 2 in stabilizing fibrin clots and supporting hemostasis. | PLoS One | 2026 | https://conductscience.org/library/papers/42555608 | PubMed |
| 42,291,738 | A comprehensive approach to elucidating the pathophysiology of kidney fibrosis based on extracellular vesicle proteomics. | Front Physiol | 2026 | https://conductscience.org/library/papers/42291738 | PubMed |
| 40,492,232 | Exploring the Potential Regulatory Mechanisms of Mitophagy in Ischemic Cardiomyopathy. | Int J Gen Med | 2025 | https://conductscience.org/library/papers/40492232 | PubMed |
| 39,574,071 | Role of transglutaminase 2 in promoting biglycan synthesis in idiopathic gingival fibromatosis. | BMC Oral Health | 2024 | https://conductscience.org/library/papers/39574071 | PubMed |
| 37,308,486 | Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37308486 | PubMed |
| 36,864,028 | Tissue transglutaminase exacerbates renal fibrosis via alternative activation of monocyte-derived macrophages. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/36864028 | PubMed |
| 35,122,964 | Latent TGFβ complexes are transglutaminase cross-linked to fibrillin to facilitate TGFβ activation. | Matrix Biol | 2022 | https://conductscience.org/library/papers/35122964 | PubMed |
| 34,360,011 | Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis. | Cells | 2021 | https://conductscience.org/library/papers/34360011 | PubMed |
| 34,206,882 | Vocal Fold Fibroblasts in Reinke's Edema Show Alterations Involved in Extracellular Matrix Production, Cytokine Response and Cell Cycle Control. | Biomedicines | 2021 | https://conductscience.org/library/papers/34206882 | PubMed |
| 31,881,614 | A Preliminary Report of the Biochemical and Clinical Effects of 1,4-Diaminobutane on Prevention of Human Hypertrophic Scars. | Plast Reconstr Surg | 2020 | https://conductscience.org/library/papers/31881614 | PubMed |
| 31,117,256 | Transglutaminase-2 Mediates the Biomechanical Properties of the Colorectal Cancer Tissue Microenvironment that Contribute to Disease Progression. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31117256 | PubMed |
| 30,847,814 | Influence of the long-term exposure to tartrazine and chlorophyll on the fibrogenic signalling pathway in liver and kidney of rats: the expression patterns of collagen 1-α, TGFβ-1, fibronectin, and caspase-3 genes. | Environ Sci Pollut Res Int | 2019 | https://conductscience.org/library/papers/30847814 | PubMed |
| 30,621,228 | Spotlight on the Transglutaminase 2-Heparan Sulfate Interaction. | Med Sci (Basel) | 2019 | https://conductscience.org/library/papers/30621228 | PubMed |
| 30,545,030 | Transglutaminases in Monocytes and Macrophages. | Med Sci (Basel) | 2018 | https://conductscience.org/library/papers/30545030 | PubMed |
| 30,038,214 | Notch ligand Delta-like 4 induces epigenetic regulation of Treg cell differentiation and function in viral infection. | Mucosal Immunol | 2018 | https://conductscience.org/library/papers/30038214 | PubMed |
| 29,743,665 | Isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis. | Sci Rep | 2018 | https://conductscience.org/library/papers/29743665 | PubMed |
| 28,250,368 | Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise? A Critical Review of the Literature in the Decade 2004-2013. | Proteomes | 2014 | https://conductscience.org/library/papers/28250368 | PubMed |
| 27,867,963 | αvβ1 integrin as a novel therapeutic target for tissue fibrosis. | Ann Transl Med | 2016 | https://conductscience.org/library/papers/27867963 | PubMed |
| 27,694,984 | Interplay between transglutaminases and heparan sulphate in progressive renal scarring. | Sci Rep | 2016 | https://conductscience.org/library/papers/27694984 | PubMed |
| 27,562,793 | P2X7 receptor-mediated TG2 externalization: a link to inflammatory arthritis? | Amino Acids | 2017 | https://conductscience.org/library/papers/27562793 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8096847
GET https://conductscience.org/api/papers/v1/8096847/references?page=2